Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis.
Respir Res
; 23(1): 54, 2022 Mar 09.
Article
in En
| MEDLINE
| ID: mdl-35264154
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Sarcoidosis
/
Drug Resistance
/
Prednisone
/
Infliximab
Type of study:
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Respir Res
Year:
2022
Document type:
Article
Affiliation country:
Saudi Arabia
Country of publication:
United kingdom